Ophthalmology · New York, NY
NPI
1578634614
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
285 Fort Washington Ave
New York, NY, 10032
Phone (212) 927-0060
Medicare paid, 2024
$21K
406 services
Medicare patients, 2024
96
Average age 80
Drug cost, 2024
$1.0M
3,940 prescriptions
Company payments, 2025
$41.16
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raphael L Vazquez was code 92012 (ophthalmological e&m), 148 times for 74 patients. In total Raphael L Vazquez billed 406 services in 12 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 148 | 74 | $71.59 | $11K |
| 92202 Ophthalmological E&M | Office | 147 | 86 | $12.59 | $1,850 |
| 92083 Vision, Hearing, and Speech Services | Office | 41 | 41 | $53.87 | $2,209 |
| 99212 Office E&M - Established | Office | 26 | 22 | $46.03 | $1,197 |
| 92014 Ophthalmological E&M | Office | 20 | 20 | $107.38 | $2,148 |
| 92004 Ophthalmological E&M | Office | 13 | 13 | $105.30 | $1,369 |
By year: 2022 $47K for 666 services; 2023 $33K for 587 services; 2024 $21K for 406 services.
Medicare prescription drug claims, 2024
In 2024, the drug Raphael L Vazquez prescribed most often to Medicare patients was Azelastine Hcl, with 987 prescriptions and refills. In total Raphael L Vazquez wrote 3,940 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 987 | 1,091 | 248 | $6,774 |
| Restasis Cyclosporine | 426 | 783 | 131 | $465K |
| Latanoprost Generic | 419 | 646 | 90 | $3,325 |
| Lumigan Bimatoprost | 349 | 694 | 89 | $189K |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 253 | 261 | 179 | $11K |
| Fluticasone Propionate Generic | 128 | 144 | 43 | $1,006 |
| Combigan Brimonidine Tartrate/Timolol | 116 | 226 | 29 | $50K |
| Dorzolamide Hcl Generic | 98 | 153 | 25 | $1,604 |
| Levocetirizine Dihydrochloride Generic | 97 | 161 | 55 | $637 |
| Tobradex Tobramycin/Dexamethasone | 88 | 88 | 58 | $22K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 85 | 156 | 30 | $1,307 |
| Vyzulta Latanoprostene Bunod | 85 | 112 | 19 | $30K |
| Alrex Loteprednol Etabonate | 83 | 112 | 32 | $39K |
| Brimonidine Tartrate Generic | 77 | 148 | 29 | $8,146 |
| Xiidra Lifitegrast | 77 | 121 | 30 | $78K |
Brand drugs: 1,739 claims; generic drugs: 2,201 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raphael L Vazquez $41.16 ($41.16 in general payments such as food, travel and fees) from 1 company. The largest payer was Bausch & Lomb Americas Inc. with $41.16.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 2 | $41.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.